Raymond James Begins Coverage on Black Diamond Therapeutics (NASDAQ:BDTX)
Raymond James initiated coverage on shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) in a report released on Wednesday morning, MarketBeat Ratings reports. The firm issued an outperform rating and a $20.00 price objective on the stock. Other research analysts also recently issued reports about the stock. Piper Sandler reaffirmed an overweight rating and […]
More Stories
US Deployments Fuel Speculation of Ground Combat Against Iran
By Ryan Morgan The U.S. military has deployed several thousand additional infantry troops to the Middle East in recent weeks,...
Remote-Job Postings Rise 20 Percent Sequentially in First Quarter: Report
By Mary Prenon While many American companies, both large and small, have called employees back to the office over the...
Acting Attorney General Blanche Rejects Speculation About Bondi’s Departure
By Jack Phillips Interim Attorney General Todd Blanche dismissed speculation that Pam Bondi left her position as attorney general in...
US Fighter Jet Downed Over Iran, One Crew Member Rescued, Search Ongoing
By Tom Ozimek Search-and-rescue efforts were underway in southern Iran on April 3 after an American fighter jet was shot...
Trump Signals Possible US Operation to Reopen Strait of Hormuz
By Tom Ozimek U.S. President Donald Trump said on April 3 that the United States could “easily” reopen the Strait...
Age of Attraction Season 2? Renewal, Couples, Release Date, and Trailer
After a positive review of the debut of season 1 on March 11, 2026, people are craving more for the...